FLUMAZENIL INJECTIO

The Defense Logistics Agency awarded a single-line item contract to DMS PHARMACEUTICAL GROUP INC with CAGE code 1UNB0 for the delivery of one vial of Flumazenil Injection, identified by NSN 6505016007434 and NDC 63323-0424-10, at a total price of $9.61. The contract was awarded on July 20, 2026, under the delivery order SPE2DX25D9900 with a required delivery date of August 4, 2026. The product is to be shipped FOB destination with the contractor responsible for all freight costs, and inspection and acceptance occur upon arrival at the designated location in Building 7244, Fort Campbell, Kentucky. Packaging and marking requirements are minimal and operationally focused, mandating traceable shipping methods, exclusion of parcel post, and labeling with a Traceable Control Number and Requested Delivery Date, but no formal MIL-STD or barcoding standards are cited. No standard FAR or DFARS contract clauses, representations, certifications, or evaluation factors are included in the documentation, and the contract lacks typical administrative details such as funding codes, contracting officer contacts, invoicing procedures, or payment office information. The procurement reflects a low-value, price-driven transaction with zero tolerance for quantity variance and no option clauses or amendments. Compliance is based on adherence to DLA supply chain protocols, and the awardee’s manufacturer CAGE code is listed as 57KZ6. The NAICS code 325412 is associated with the awardee, though no small business or socioeconomic status is confirmed. The contract appears to be executed through streamlined DLA procedures, with limited formal documentation beyond delivery specifications and pricing.